BioCryst´s Zika drug shows promise in mice
 

BioCryst Pharmaceuticals Inc said on Monday a dose of its experimental antiviral drug improved survival rates in mice infected with the Zika virus in a preclinical study.Two doses of the drug, BCX443, were tested against a placebo and an oral...http://feeds.feedburner.com/~r/com/YEor/~4/D02LiQd-99s

أكثر...